1 Department of Bioengineering, University of Pittsburgh , Pittsburgh, Pennsylvania.
2 The McGowan Institute for Regenerative Medicine, University of Pittsburgh , Pittsburgh, Pennsylvania.
Tissue Eng Part A. 2017 Dec;23(23-24):1382-1393. doi: 10.1089/ten.TEA.2017.0027. Epub 2017 Jun 27.
Bone tissue engineering requires the upregulation of several regenerative stages, including a critical early phase of angiogenesis. Previous studies have suggested that a sequential delivery of platelet-derived growth factor (PDGF) to bone morphogenetic protein-2 (BMP-2) could promote angiogenic tubule formation when delivered to in vitro cocultures of human umbilical vein endothelial cells (HUVECs) and human mesenchymal stem cells (hMSCs). However, it was previously unclear that this PDGF to BMP-2 delivery schedule will result in cell migration into the scaffolding system and affect the later expression of bone markers. Additionally, a controlled delivery system had not yet been engineered for programmed sequential presentation of this particular growth factor. By combining alginate matrices with calcium phosphate scaffolding, a programmed growth factor delivery schedule was achieved. Specifically, a combination of alginate microspheres, alginate hydrogels, and a novel blend of resorbable calcium phosphate-based cement (ReCaPP) was used. PDGF and BMP-2 were sequentially released from this hybrid calcium phosphate/alginate scaffold with the desired 3-day overlap in PDGF to BMP-2 delivery. Using a three-dimensional coculture model, we observed that this sequence of PDGF to BMP-2 delivery influenced both cellular infiltration and alkaline phosphatase (ALP) expression. It was found that the presence of early PDGF delivery increased the distance of cell infiltration into the calcium phosphate/alginate scaffolding in comparison to early BMP-2 delivery and simultaneous PDGF+BMP-2 delivery. It was also observed that hMSCs expressed a greater amount of ALP+ staining in response to scaffolds delivering the sequential PDGF to BMP-2 schedule, when compared with scaffolds delivering no growth factor, or PDGF alone. Importantly, hMSCs cultured with scaffolds releasing the PDGF to BMP-2 schedule showed similar amounts of ALP staining to hMSCs cultured with BMP-2 alone, suggesting that the sequential schedule of PDGF to BMP-2 presentation promotes differentiation of hMSCs toward an osteoblast phenotype while also increasing cellular infiltration of the scaffold.
骨组织工程需要上调几个再生阶段,包括血管生成的关键早期阶段。先前的研究表明,当将血小板衍生生长因子(PDGF)顺序递送至体外共培养的人脐静脉内皮细胞(HUVEC)和人骨髓间充质干细胞(hMSC)中时,骨形态发生蛋白-2(BMP-2)可促进血管生成管的形成。然而,先前不清楚这种 PDGF 到 BMP-2 的递药方案是否会导致细胞迁移到支架系统中,并影响后期骨标志物的表达。此外,尚未设计出用于程序性递呈这种特定生长因子的控释系统。通过将藻酸盐基质与磷酸钙支架相结合,实现了程序性生长因子递药方案。具体来说,使用了藻酸盐微球、藻酸盐水凝胶和新型可吸收磷酸钙基水泥(ReCaPP)的混合物。PDGF 和 BMP-2 从这种混合的磷酸钙/藻酸盐支架中顺序释放,PDGF 到 BMP-2 递药之间有 3 天的重叠。使用三维共培养模型,我们观察到这种 PDGF 到 BMP-2 递药顺序既影响细胞浸润又影响碱性磷酸酶(ALP)表达。结果发现,与早期 BMP-2 递药和 PDGF+BMP-2 同时递药相比,早期 PDGF 递药增加了细胞渗透到磷酸钙/藻酸盐支架中的距离。还观察到,与未递送生长因子或仅递送 PDGF 的支架相比,响应递药顺序为 PDGF 到 BMP-2 的支架,hMSC 表达了更多的 ALP+染色。重要的是,用释放 PDGF 到 BMP-2 方案的支架培养的 hMSC 显示出与单独用 BMP-2 培养的 hMSC 相似的 ALP 染色量,这表明 PDGF 到 BMP-2 递呈的顺序方案可促进 hMSC 向成骨细胞表型分化,同时增加支架的细胞浸润。